Policy Comments
The priority legislative and regulatory issues that the Cancer Policy Institute focuses on are driven by policy pillars that are centered around the values, needs, and preferences of individuals impacted by cancer. We work in conjunction with patients, patient advocacy organizations, medical associations, and other stakeholders to advance policies aimed at improving access to, affordability of, and quality of care across the cancer continuum.
Comments and recommendations to CMS including innovative and meaningful actions from CMS to support patient access to CAR T, continue and increase stakeholder and patient engagement, and consider new technology add-on payment (NTAP).
Letter urging Congress to address the urgent need of cancer care affordability and pass reconciliation legislation that permanently extends expanded subsidies in the Affordable Care Act marketplaces, permanently fixes the Medicaid “coverage gap,” and enacts a cap on out-of-pocket costs for Medicare Part D beneficiaries.
Comments on the impact of PBM practices on patients all framed within the context of accumulator adjustment programs and their impact on patients.